CT-base pulmonary artery measurementin the detection of pulmonary hypertension: a meta-analysis and systematic Review

Y Shen, C Wan, P Tian, Y Wu, X Li, T Yang, J An… - Medicine, 2014 - journals.lww.com
CT-Base Pulmonary Artery Measurementin the Detection of Pulm... : Medicine CT-Base
Pulmonary Artery Measurementin the Detection of Pulmonary Hypertension: A Meta-Analysis …

Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)

Y Jiang, MA Turk, JE Pope - Autoimmunity reviews, 2020 - Elsevier
Background Pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) is a lethal
complication affecting 8–15% of patients. Screening tests such as echocardiography and …

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma …

ND Morgan, AA Shah, MD Mayes, RT Domsic… - Medicine, 2017 - journals.lww.com
Racial differences exist in the severity of systemic sclerosis (SSc). To enhance our
knowledge about SSc in African Americans, we established a comprehensive clinical …

Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis

A Young, D Vummidi, S Visovatti, K Homer… - Arthritis & …, 2019 - Wiley Online Library
Objective Systemic sclerosis (SS c) is associated with interstitial lung disease (ILD) and
pulmonary hypertension (PH). This study was undertaken to determine the prevalence …

Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study

M Hughes, E Zanatta, RD Sandler, J Avouac… - …, 2022 - academic.oup.com
Abstract Objectives Vascular disease in SSc is associated with significant morbidity and
mortality. Preliminary data may lead to the suggestion of a modifiable unified-vascular …

Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis

E Vandecasteele, M De Pauw, F De Keyser… - International Journal of …, 2016 - Elsevier
Background Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are
the leading causes of death in systemic sclerosis (SSc). Although the six-minute walk test …

Progress in understanding, diagnosing, and managing cardiac complications of systemic sclerosis

G Hung, V Mercurio, S Hsu, SC Mathai… - Current rheumatology …, 2019 - Springer
Abstract Purpose of the Review Systemic sclerosis (scleroderma) is a complex autoimmune
disease that commonly involves the cardiovascular system. Even if often subclinical, cardiac …

Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the PHAROS registry

VM Hsu, L Chung, LK Hummers, A Shah… - The Journal of …, 2019 - jrheum.org
Objective. We sought to identify predictors of mortality and cardiopulmonary hospitalizations
in patients at risk for pulmonary hypertension (PH) and enrolled in PHAROS, a prospective …

Ethnicity in pulmonary arterial hypertension: possibilities for novel phenotypes in the age of personalized medicine

SK Medrek, S Sahay - Chest, 2018 - Elsevier
In the past decade and a half, the introduction of new therapeutic agents has revolutionized
the management of pulmonary arterial hypertension (PAH). These new treatment options …

Genetic admixture and survival in diverse populations with pulmonary arterial hypertension

JH Karnes, HW Wiener, TH Schwantes-An… - American journal of …, 2020 - atsjournals.org
Rationale: Limited information is available on racial/ethnic differences in pulmonary arterial
hypertension (PAH). Objectives: Determine effects of race/ethnicity and ancestry on mortality …